Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR)
Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR)
Background: biannual distribution of azithromycin to children 1–59 months old reduced mortality by 14% in a cluster-randomized trial. The World Health Organization has proposed targeting this intervention to the subgroup of children 1–11 months old to reduce selection for antimicrobial resistance. Here, we describe a trial designed to determine the impact of age-based targeting of biannual azithromycin on mortality and antimicrobial resistance.
Methods: AVENIR is a cluster-randomized, placebo-controlled, double-masked, response-adaptive large simple trial in Niger. During the 2.5-year study period, 3350 communities are targeted for enrollment. In the first year, communities in the Dosso region will be randomized 1:1:1 to 1) azithromycin 1–11: biannual azithromycin to children 1–11 months old with placebo to children 12–59 months old, 2) azithromycin 1–59: biannual azithromycin to children 1–59 months old, or 3) placebo: biannual placebo to children 1–59 months old. Regions enrolled after the first year will be randomized with an updated allocation based on the probability of mortality in children 1–59 months in each arm during the preceding study period. A biannual door-to-door census will be conducted to enumerate the population, distribute azithromycin and placebo, and monitor vital status. Primary mortality outcomes are defined as all-cause mortality rate (deaths per 1000 person-years) after 2.5 years from the first enrollment in 1) children 1–59 months old comparing the azithromycin 1–59 and placebo arms, 2) children 1–11 months old comparing the azithromycin 1–11 and placebo arm, and 3) children 12–59 months in the azithromycin 1–11 and azithromycin 1–59 arms. In the Dosso region, 50 communities from each arm will be followed to monitor antimicrobial resistance. Primary resistance outcomes will be assessed after 2 years of distributions and include 1) prevalence of genetic determinants of macrolide resistance in nasopharyngeal samples from children 1–59 months old, and 2) load of genetic determinants of macrolide resistance in rectal samples from children 1–59 months old.
Discussion: as high-mortality settings consider this intervention, the results of this trial will provide evidence to support programmatic and policy decision-making on age-based strategies for azithromycin distribution to promote child survival. Trial registration: This trial was registered on January 13, 2020 (clinicaltrials.gov: NCT04224987).
Adaptive trial, Azithromycin, Cluster-randomized trial, Mass drug administration, Mortality
O’Brien, Kieran S.
a3d8b41a-bbe7-4605-a878-a9d9fa434fd9
Arzika, Ahmed M.
dad97d43-324e-4c17-8406-67732aede3b5
Amza, Abdou
7612c3f7-6016-46ed-9092-bf859ea89254
Maliki, Ramatou
0725e25c-078a-4189-99d7-e97584103094
Ousmane, Sani
41813dee-6528-40f7-b39b-b38ffa527fe4
Kadri, Boubacar
ed6fc199-6e74-4310-9a67-354db31ffc64
Nassirou, Beido
ebe07907-bade-4466-b084-a7194a37183d
Mankara, Alio Karamba
c7e8800c-a37f-4459-b781-856f9bcedfe1
Harouna, Abdoul Naser
8086d4e4-5446-4e6e-a7f0-81b4da3c499e
Colby, Emily
53ff89e3-0536-4efc-b3dd-469977194d22
Lebas, Elodie
11d2e4c2-6875-4ec7-ac4d-086d918eb9a2
Liu, Zijun
59936dfd-4781-4dac-9790-5f63f4b20ebc
Le, Victoria
665671a4-299c-4586-899b-7f8124f42c78
Nguyen, William
50184e49-310d-4cd9-b2d4-b81515e25c38
Keenan, Jeremy D.
6875b957-ac7c-4cd9-99ea-14ca0dcbd46d
Oldenburg, Catherine E.
3509ac92-72cc-4146-a844-9a0b6024d2b8
Porco, Travis C.
d55a2651-6edc-4a24-8176-4acf25f8b363
Doan, Thuy
cac98e5a-120d-461a-8da1-b5b735dbe1dd
Arnold, Benjamin F.
8be36b05-718d-405b-80a6-73ea2c1019e3
Lietman, Thomas M.
8fd3bd9b-5cd1-4c07-8302-af157cc66d25
De Borman, Nicolas
34cee659-7ff4-4249-a783-20dbf0077c5b
Dresse, Stephane
fe4d646b-a984-4e65-8524-ed357070b3fe
Olekhnovitch, Romain
20a2bf4b-2472-42a7-88c4-943a3c3030ff
Lurton, Grégoire
6cbd4b56-752c-4b4c-906d-f457635d965c
Monchy, Léa
986a7104-98e3-4642-a953-9af1bb1112a1
De Wulf, Martin
62c8432b-a291-41f0-97e8-efbe1e6da181
Brander, Rebecca
008d18b7-0705-4fe3-b6f3-86c9d0ab192e
Chao, Dennis
8897bef4-5d28-48b5-bb94-da3cb8a61482
Heine, James
4b0ec5cd-3ddb-4410-9ab7-266236716c02
Izadnegahdar, Rasa
169f0cdb-913a-4893-a893-6c53d1880c48
Lamberti, Laura
9847d8f5-f60b-458b-b441-efff436390dd
Oron, Assaf
4c18dc6a-b222-40aa-8482-c5fc4913f95b
Rajaram, Surabhi
1e6b31c1-cb98-45e1-83ab-947aae085283
Steele, Matthew
beb84522-d10f-4687-a238-7412e9552326
Seyfoule, Amina
499241f7-16b7-48ec-a644-60ae82b7ac21
Arzika, Ahmed
3400b60b-482e-46eb-bb17-447b7bc3943b
Bello, Fati
914ee926-569f-45dc-9373-4b9ae7d0707b
Boubacar, Diallo
08e95a04-e508-4a49-9697-d57c12cc7977
Harouna, Amadou
733453a7-7211-4b8c-8b3b-d3e2e4da472c
Karamba, Alio
2944af7a-3b61-489b-a087-8fa2f90c1e06
Nomao, Farissat
4c321d94-5f23-41bb-8009-dfc145a7119b
Omar, Abraham
19fb960c-eab4-41a7-99b9-e6b5993295f4
Issa, Ibrahima
1e419fb9-e1cb-4839-985c-660eaaa83db4
Jambou, Ronan
ff8632b7-e91c-4d30-bee2-c623e70e9414
Labbo, Rabiou
df4289d7-2d11-4189-be0b-ee3e2c40e088
Lamine, S’ Hooshim N.
e15a81b3-35fa-49c1-bfb7-962f2c028c90
Rakia, Boubakar
e049fbb9-17d0-42b0-878a-4e5e33dca14d
Boo, Gianluca
d49f7aaa-6d95-4e36-b9be-e469911c4a3d
Darin, Edith
868fa688-2567-4dbd-aa12-3dcc91f2aa8d
Tatem, Andy
6c6de104-a5f9-46e0-bb93-a1a7c980513e
29 April 2021
O’Brien, Kieran S.
a3d8b41a-bbe7-4605-a878-a9d9fa434fd9
Arzika, Ahmed M.
dad97d43-324e-4c17-8406-67732aede3b5
Amza, Abdou
7612c3f7-6016-46ed-9092-bf859ea89254
Maliki, Ramatou
0725e25c-078a-4189-99d7-e97584103094
Ousmane, Sani
41813dee-6528-40f7-b39b-b38ffa527fe4
Kadri, Boubacar
ed6fc199-6e74-4310-9a67-354db31ffc64
Nassirou, Beido
ebe07907-bade-4466-b084-a7194a37183d
Mankara, Alio Karamba
c7e8800c-a37f-4459-b781-856f9bcedfe1
Harouna, Abdoul Naser
8086d4e4-5446-4e6e-a7f0-81b4da3c499e
Colby, Emily
53ff89e3-0536-4efc-b3dd-469977194d22
Lebas, Elodie
11d2e4c2-6875-4ec7-ac4d-086d918eb9a2
Liu, Zijun
59936dfd-4781-4dac-9790-5f63f4b20ebc
Le, Victoria
665671a4-299c-4586-899b-7f8124f42c78
Nguyen, William
50184e49-310d-4cd9-b2d4-b81515e25c38
Keenan, Jeremy D.
6875b957-ac7c-4cd9-99ea-14ca0dcbd46d
Oldenburg, Catherine E.
3509ac92-72cc-4146-a844-9a0b6024d2b8
Porco, Travis C.
d55a2651-6edc-4a24-8176-4acf25f8b363
Doan, Thuy
cac98e5a-120d-461a-8da1-b5b735dbe1dd
Arnold, Benjamin F.
8be36b05-718d-405b-80a6-73ea2c1019e3
Lietman, Thomas M.
8fd3bd9b-5cd1-4c07-8302-af157cc66d25
De Borman, Nicolas
34cee659-7ff4-4249-a783-20dbf0077c5b
Dresse, Stephane
fe4d646b-a984-4e65-8524-ed357070b3fe
Olekhnovitch, Romain
20a2bf4b-2472-42a7-88c4-943a3c3030ff
Lurton, Grégoire
6cbd4b56-752c-4b4c-906d-f457635d965c
Monchy, Léa
986a7104-98e3-4642-a953-9af1bb1112a1
De Wulf, Martin
62c8432b-a291-41f0-97e8-efbe1e6da181
Brander, Rebecca
008d18b7-0705-4fe3-b6f3-86c9d0ab192e
Chao, Dennis
8897bef4-5d28-48b5-bb94-da3cb8a61482
Heine, James
4b0ec5cd-3ddb-4410-9ab7-266236716c02
Izadnegahdar, Rasa
169f0cdb-913a-4893-a893-6c53d1880c48
Lamberti, Laura
9847d8f5-f60b-458b-b441-efff436390dd
Oron, Assaf
4c18dc6a-b222-40aa-8482-c5fc4913f95b
Rajaram, Surabhi
1e6b31c1-cb98-45e1-83ab-947aae085283
Steele, Matthew
beb84522-d10f-4687-a238-7412e9552326
Seyfoule, Amina
499241f7-16b7-48ec-a644-60ae82b7ac21
Arzika, Ahmed
3400b60b-482e-46eb-bb17-447b7bc3943b
Bello, Fati
914ee926-569f-45dc-9373-4b9ae7d0707b
Boubacar, Diallo
08e95a04-e508-4a49-9697-d57c12cc7977
Harouna, Amadou
733453a7-7211-4b8c-8b3b-d3e2e4da472c
Karamba, Alio
2944af7a-3b61-489b-a087-8fa2f90c1e06
Nomao, Farissat
4c321d94-5f23-41bb-8009-dfc145a7119b
Omar, Abraham
19fb960c-eab4-41a7-99b9-e6b5993295f4
Issa, Ibrahima
1e419fb9-e1cb-4839-985c-660eaaa83db4
Jambou, Ronan
ff8632b7-e91c-4d30-bee2-c623e70e9414
Labbo, Rabiou
df4289d7-2d11-4189-be0b-ee3e2c40e088
Lamine, S’ Hooshim N.
e15a81b3-35fa-49c1-bfb7-962f2c028c90
Rakia, Boubakar
e049fbb9-17d0-42b0-878a-4e5e33dca14d
Boo, Gianluca
d49f7aaa-6d95-4e36-b9be-e469911c4a3d
Darin, Edith
868fa688-2567-4dbd-aa12-3dcc91f2aa8d
Tatem, Andy
6c6de104-a5f9-46e0-bb93-a1a7c980513e